In both phenotypes, endothelin-1 (ET-1) is upregulated, leading to imbalanced vasoconstriction, ischemic-reperfusion events, metabolic impairments with cascading complications, aging and related pathologies, cardiovascular diseases, neurodegenerative pathologies, and aggressive malignancies [294]. This evidence concerns the gene EDN1 and cardiovascular disorder.